Clinical Trials
6
Active:0
Completed:6
Trial Phases
2 Phases
Phase 2:2
Phase 3:4
Drug Approvals
237
TGA:231
NMPA:6
Drug Approvals
Drospirenone and EthinylEstradiol tablets (Ⅱ)
- Product Name
- 屈螺酮炔雌醇片(Ⅱ)
- Approval Number
- 国药准字HJ20140972
- Approval Date
- Oct 30, 2023
NMPA
Drospirenone and Ethinylestradiol Tablets
- Product Name
- 优思明
- Approval Number
- 国药准字HJ20170316
- Approval Date
- Mar 21, 2022
NMPA
Drospirenone and Ethinylestradiol Tablets
- Product Name
- 优思明
- Approval Number
- 国药准字HJ20170317
- Approval Date
- Mar 21, 2022
NMPA
Drospirenone and EthinylEstradiol tablets(Ⅱ)
- Product Name
- 屈螺酮炔雌醇片(Ⅱ)
- Approval Number
- H20140972
- Approval Date
- May 31, 2019
NMPA
Aflibercept Intravitreous Injection
- Product Name
- 艾力雅
- Approval Number
- S20180001
- Approval Date
- Feb 2, 2018
NMPA
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 3
4 (66.7%)Phase 2
2 (33.3%)No trials found
News
No news found